Open AccessTamsulosin and Tadalafil in Relieving Benign Prostatic Hyperplasia Related Symptoms- A Comparative Study
Author(s) -
A. Nischal Prasad,
Nand Kumar B. Madhekar
Publication year - 2020
Publication title -
academia journal of surgery
Language(s) - English
Resource type - Journals
eISSN - 2663-8347
pISSN - 2663-8339
DOI - 10.47008/ajs/2020.3.1.17
Subject(s) - medicine , tadalafil , tamsulosin , hyperplasia , urology , international prostate symptom score , diabetes mellitus , benign prostatic hyperplasia (bph) , placebo , erectile dysfunction , prostate , lower urinary tract symptoms , endocrinology , alternative medicine , pathology , cancer
Background: Benign prostatic hyperplasia (BPH) is the most common neoplastic condition afflicting men and constitutes a major factor impact- ing the health of the male. The present study compared tamsulosin and tadalafil in relieving benign prostatic hyperplasia related symptoms in patients. Subjects and Methods: The present study was conducted at NRI Medical College & Hospital, Chinakakani, Mangalagiri Mandal, Andhra Pradesh from April 2007 to March 2008 on 82 men of >45 years of age with LUTS secondary to benign prostatic hyperplasia (BPH) with an IPSS >8. All patients were divided into 2 weeks. In group I, Tadalafil 10 mg once daily with an intervening 4-week period of placebo (P4) wash out followed by Tamsulosin 0.4 mg once daily were administered for a period of 6 weeks and in group II, reverse of it was administered. IPSS scores, Uroflowmetry parameters and International Index of Erectile Function-5 scores were recorded in both groups. Results: Age group 45- 55 years had 12, 55-65 years had 28 and >65 years had 42 patients. The difference was significant (P 0.05). Conclusion: Authors found that both Tadalafil and Tamsulosin improved LUTS and benign prostrate hyperplasia symptoms.